Tfg Asset Management Gp LTD Celldex Therapeutics, Inc. Transaction History
Tfg Asset Management Gp LTD
- $346 Million
- Q1 2025
A detailed history of Tfg Asset Management Gp LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 261,000 shares of CLDX stock, worth $5.6 Million. This represents 1.37% of its overall portfolio holdings.
Number of Shares
261,000
Previous 192,000
35.94%
Holding current value
$5.6 Million
Previous $4.85 Million
2.35%
% of portfolio
1.37%
Previous 1.59%
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
194Shares Held
69.8MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$179 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$139 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$83.6 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$80.5 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...